# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000310158-21-000004
Filing Date
2021-02-25
Accepted
2021-02-25 16:34:56
Documents
141
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | mrk-20201231.htm iXBRL | 10-K | 6620114
2 | EX-4.10 DESCRIPTION OF MERCK COMMON STOCK | exhibit410-merckdescriptio.htm | EX-4.10 | 20544
3 | EX-4.11 DESCRIPTION OF 2021 NOTES, 2026 NOTES, AND 2034 NOTES | exhibit411-merckdescriptio.htm | EX-4.11 | 112330
4 | EX-4.12 DESCRIPTION OF 2024 NOTES AND 2036 NOTES | exhibit412-merckdescriptio.htm | EX-4.12 | 109927
5 | EX-10.23 2021 NQSO GRANT TERMS UNDER MERCK CO INC 2019 ISP | ex10-24x2021annualrsuterms.htm | EX-10.23 | 39602
6 | EX-10.24 2021 RSU GRANT TERMS UNDER MERCK CO INC 2019 ISP | ex1023-2021annualnqsoterms.htm | EX-10.24 | 38358
7 | EX-21 SUBSIDIARY LIST | ex21-subsidiarylistasof12x.htm | EX-21 | 436749
8 | EX-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ex23-consentofindependentr.htm | EX-23 | 2585
9 | EX-24.1 POWER OF ATTORNEY | ex241-powerofattorney.htm | EX-24.1 | 14827
10 | EX-24.2 CERTIFICATION OF BOARD RESOLUTION | ex242-certificationofboard.htm | EX-24.2 | 7084
11 | EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | ex311-rule13ax14a15dx14ace.htm | EX-31.1 | 8359
12 | EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | ex312-rule13ax14a15dx14ace.htm | EX-31.2 | 8397
13 | EX-32.1 SECTION 1350 CERTIFICATION OF CEO | ex321-section1350certifica.htm | EX-32.1 | 4172
14 | EX-32.2 SECTION 1350 CERTIFICATION OF CFO | ex322-section1350certifica.htm | EX-32.2 | 3955
20 |  | mrk-20201231_g1.jpg | GRAPHIC | 78579
21 |  | mrk-20201231_g2.jpg | GRAPHIC | 25396
22 |  | mrk-20201231_g3.jpg | GRAPHIC | 7017
23 |  | mrk-20201231_g4.jpg | GRAPHIC | 31485
| Complete submission text file | 0000310158-21-000004.txt |  | 29150063

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20201231.xsd | EX-101.SCH | 111248
16 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20201231_cal.xml | EX-101.CAL | 188602
17 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20201231_def.xml | EX-101.DEF | 811703
18 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20201231_lab.xml | EX-101.LAB | 1441744
19 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20201231_pre.xml | EX-101.PRE | 1081023
24 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20201231_htm.xml | XML | 7194519

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 21680913
SIC: 2834 Pharmaceutical Preparations